Search

everythinglearnresearchcommunity

for

Search:↓

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

PRP more effective than minoxidil 5% for treating alopecia areata.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

More research is needed to find the best long-term treatments for Alopecia Areata.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.